Results 141 to 150 of about 178,510 (340)

Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors.
Eric L. Simpson   +12 more
wiley   +1 more source

Gut microbiota modulation: a key determinant of atopic dermatitis susceptibility in children

open access: yesFrontiers in Microbiology
Atopic dermatitis is a chronic inflammatory skin condition with a higher incidence rate among children. In recent years, the role of the gut microbiota in the pathogenesis of atopic dermatitis has garnered increasing attention. This review systematically
Huimiao Tang   +9 more
doaj   +1 more source

Healthcare Service Utilization by 116,816 Patients with Atopic Dermatitis in Israel

open access: yesActa Dermato-Venereologica, 2019
Understanding of the epidemiology and healthcare service utilization related to atopic dermatitis is necessary to inform the use of new treatments. This cross-sectional study was based on a group of patients with atopic dermatitis and a matched control ...
Guy Shalom   +10 more
doaj   +1 more source

A case of tinea incognito mimicking subcorneal pustular dermatosis [PDF]

open access: yes, 2020
An 89-year-old woman presented with plaque-like lesions, accompanied with pustules and desquamation on the back and front of the trunk for approximately one year. Long term use of potent topical corticosteroids was ineffective.
Aktaş, Akın   +3 more
core  

Teledermatology (Live Video Conferencing) Network Devoted to Competition Swimmers in France

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Dermatology was one of the medical specialties that pioneered telemedicine. Store‐and‐forward and live video conferencing (LVC) solutions have been developed throughout the world in response to structural challenges (e.g. medical deserts) or situational needs (e.g. COVID‐19 pandemic).
E. Mahé
wiley   +1 more source

Probiotics in Atopic Dermatitis: Where do We Stand?

open access: diamond, 2023
Rashmi Agarwal   +3 more
openalex   +1 more source

The burden of atopic dermatitis in Portuguese patients: an observational study

open access: yesScientific Reports
Atopic dermatitis (AD) is a common inflammatory skin condition that significantly affects patients' lives and imposes both economic and non-economic burdens. The precise societal and individual consequences of AD remain incompletely understood.
Pedro S. Coelho   +5 more
doaj   +1 more source

Stillbirth in pregnancies with flat OGTT: Placental clues to occult maternal dysmetabolism

open access: yes
International Journal of Gynecology &Obstetrics, EarlyView.
Emma Bertucci   +10 more
wiley   +1 more source

Recurrence Rates in Paediatric Patients With Atopic Dermatitis: A Comparison Between Topical and Systemic Treatments

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Atopic dermatitis (AD) is a chronic, relapsing skin condition that significantly affects children and their families. Treatment ranges from topical to systemic therapies, but evidence on long‐term recurrence following different treatment strategies in paediatric AD remains limited.
Frederikke Seeberg   +3 more
wiley   +1 more source

LB1740 Role of host epigenetics with skin microbiome in atopic dermatitis [PDF]

open access: bronze, 2023
Yik Weng Yew   +13 more
openalex   +1 more source

Home - About - Disclaimer - Privacy